Spoken Alpha · Executive
Martin H Huber Jr
PRESIDENT AND HEAD OF R&DatXLOXilio Therapeutics, Inc. In our data from Jun 15, 2022
Tracked across 2 earnings calls in our data since 2021.
Our data window: 2020–present. Actual tenure for some executives extends earlier — see company bio for full history.
Research tier
See how this executive's language deviates from their own baseline
Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.